美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

SATELLOS BIOSCIENCE INC.

8.56

-1.4400-14.40%

成交量：22.38萬

成交額：194.38萬

市值：1.77億

市盈率：-5.26

高：9.89

開：9.89

低：8.19

收：10.00

52周最高：13.39

52周最低：8.15

股本：2,062.69萬

流通股本：1,751.03萬

量比：1.82

換手率：1.28%

股息：- -

股息率：- -

每股收益(TTM):-1.6288

每股收益(LYR):-2.0417

淨資產收益率：-87.59%

總資產收益率：-54.25%

市淨率：5.19

市盈率(LYR):-4.19

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

SATELLOS BIOSCIENCE INC.

交易所：

NASDAQ

成立時間：

2018

員工人數：

16

公司地址：

Royal Bank Plaza,Suite 2800,South Tower,200 Bay Street,Toronto,Ontario,Canada

官網：

http://www.satellos.com

郵編：

M5J 2J1

電話：

- -

傳真：

- -

簡介：

Satellos Bioscience Inc.於2006年4月20日根據《商業公司法》（不列顛哥倫比亞省）註冊成立。該公司是一家臨床階段的藥物開發公司，致力於開發退行性肌肉疾病的治療方法。其主要候選藥物SAT-3247是一種口服小分子，旨在恢復杜氏肌營養不良症等情況下的骨骼肌再生。該候選藥物目前正在兩項名為BASECAMP和TRAILHEAD的試驗中進行臨床評估。該公司繼續利用其專有的MyoReGenX平台來確定退行性肌肉疾病的額外治療機會。

董事

名稱

職位

Frank Gleeson

President and Chief Executive Officer and Director

Geoff MacKay

Non-Executive Director and Chairman

Adam Mostafa

Non-Executive Director

Brian Bloom

Non-Executive Director

Franklin Berger

Non-Executive Director

Iris Loew Friedrich

Non-Executive Director

Mark Nawacki

Non-Executive Director

Selwyn Ho

Non-Executive Director

Stephanie Brown

Non-Executive Director

股東

名稱

職位

Frank Gleeson

President and Chief Executive Officer and Director

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MSLE/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MSLE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSLE\",,,,,undefined,":{"symbol":"MSLE","market":"US","secType":"STK","nameCN":"SATELLOS BIOSCIENCE INC.","latestPrice":8.56,"timestamp":1773345600000,"preClose":10,"halted":0,"volume":223760,"delay":0,"changeRate":-0.14399999999999996,"floatShares":17510300,"shares":20626900,"eps":-1.628829,"marketStatus":"盤前交易","change":-1.44,"latestTime":"03-13 07:23:33 EDT","open":9.89,"high":9.89,"low":8.19,"amount":1943842.4313,"amplitude":0.17,"askPrice":13.61,"askSize":100,"bidPrice":6.41,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-1.628829,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1773408600000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":8.56,"postHourTrading":{"tag":"盘后","latestPrice":8.56,"preClose":8.56,"latestTime":"16:10 EDT","volume":1,"amount":8.56,"timestamp":1773346204931,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.8244125778587075},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSLE\",,,,,undefined,":{"symbol":"MSLE","floatShares":17510300,"roa":"-54.25%","roe":"-87.59%","lyrEps":-2.041736,"volumeRatio":1.8244125778587075,"shares":20626900,"dividePrice":0,"high":9.89,"amplitude":0.17,"preClose":10,"low":8.19,"week52Low":8.15,"pbRate":"5.19","week52High":13.3949,"institutionHeld":0,"latestPrice":8.56,"eps":-1.628829,"divideRate":0,"volume":223760,"delay":0,"ttmEps":-1.628829,"open":9.89,"prevYearClose":12.5,"prevWeekClose":12.05,"prevMonthClose":12.35,"prevQuarterClose":12.5,"fiveDayClose":12.33,"twentyDayClose":11.64},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MSLE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-06","symbol":"MSLE","reason":null,"defaultRemindTime":1770388200000,"announcedDate":"2026-02-05","type":"delisting","dateTimestamp":1770354000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MSLE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MSLE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1773288000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MSLE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MSLE","date":"2026-03-12","current":-5.255309,"percent":0.954545,"low":-12.479818,"twenty":-11.553301,"median":-10.918938,"eighty":-10.686878,"high":-8.995645,"avg":-11.017755,"sd":0.741467,"marketCap":204418850.85},"quantilePoints":[{"date":"2026-02-13","current":-10.770362,"twenty":-10.948162,"median":-10.770362,"eighty":-10.650272,"marketCap":232264709.51},{"date":"2026-02-20","current":-10.655876,"twenty":-10.961105,"median":-10.795625,"eighty":-10.660269,"marketCap":229795787.77},{"date":"2026-02-27","current":-11.410036,"twenty":-11.040635,"median":-10.847134,"eighty":-10.698718,"marketCap":246059372.56},{"date":"2026-03-06","current":-11.830077,"twenty":-11.717077,"median":-10.918938,"eighty":-10.750564,"marketCap":255117626.85},{"date":"2026-03-12","current":-9.47912,"twenty":-11.553301,"median":-10.918938,"eighty":-10.686878,"marketCap":204418850.85}],"updateTime":1773400996534},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":650365067,"yearFounded":2018,"employeeNum":16,"address":"Royal Bank Plaza,Suite 2800,South Tower,200 Bay Street,Toronto,Ontario,Canada","zipCode":"M5J 2J1"},"stockCompanyDetail":{"websiteUrl":"http://www.satellos.com","stockEarnings":[{"period":"1week","weight":-0.3058},{"period":"1month","weight":-0.2125},{"period":"3month","weight":-0.3152},{"period":"ytd","weight":-0.3152}],"compareEarnings":[{"period":"1week","weight":-0.0224},{"period":"1month","weight":-0.0377},{"period":"3month","weight":-0.023},{"period":"6month","weight":0.0132},{"period":"1year","weight":0.1918},{"period":"ytd","weight":-0.0233}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Satellos Bioscience Inc.於2006年4月20日根據《商業公司法》（不列顛哥倫比亞省）註冊成立。該公司是一家臨床階段的藥物開發公司，致力於開發退行性肌肉疾病的治療方法。其主要候選藥物SAT-3247是一種口服小分子，旨在恢復杜氏肌營養不良症等情況下的骨骼肌再生。該候選藥物目前正在兩項名為BASECAMP和TRAILHEAD的試驗中進行臨床評估。該公司繼續利用其專有的MyoReGenX平台來確定退行性肌肉疾病的額外治療機會。","exchange":"NASDAQ","name":"SATELLOS BIOSCIENCE INC.","nameEN":"SATELLOS BIOSCIENCE INC."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MSLE\",market:\"US\",,,undefined,":{"directors":[{"name":"Frank Gleeson","position":"President and Chief Executive Officer and Director"},{"name":"Geoff MacKay","position":"Non-Executive Director and Chairman"},{"name":"Adam Mostafa","position":"Non-Executive Director"},{"name":"Brian Bloom","position":"Non-Executive Director"},{"name":"Franklin Berger","position":"Non-Executive Director"},{"name":"Iris Loew Friedrich","position":"Non-Executive Director"},{"name":"Mark Nawacki","position":"Non-Executive Director"},{"name":"Selwyn Ho","position":"Non-Executive Director"},{"name":"Stephanie Brown","position":"Non-Executive Director"}],"executives":[{"name":"Frank Gleeson","position":"President and Chief Executive Officer and Director"}]}}}